Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A00848-49 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Adaptated Physical Activity (APA) during treatment of cancer is one of the actual global health recommendation because of the benefits observed in several parameters evaluated in many clinical studies. A best knowledge of the physical and medical characteristics of patients, including type of cancer and type of treatment, is primordial to optimize the patient care and the effectiveness of APA programs.
Descriptive, explorative and prospective study of 3 different populations:
One population with locally advanced or metastatic non-small cell lung cancer treated with multiple therapeutic lines. Two different populations of early cancer patients and treated with a platinum-based regimen for colon cancer and a taxane-based chemotherapy for breast cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| experimental: observational cohort | Experimental | Evaluation of the physical condition and the quality of life |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Adaptated Physical Activity | Other | Evaluation of the physical condition and the quality of life during the course of treatment (after 8 weeks of treatment) and at the end of the treatment's line (except for breast cancer patients) |
| Measure | Description | Time Frame |
|---|---|---|
| evolution of exercise tolerance | To describe exercise tolerance, by a six-minute walk test, in patients treated for a cancer (of lung, breast or colon) after 8 weeks of treatment. | change from baseline exercise tolerance at 12 weeks after the end of the treatment |
| Measure | Description | Time Frame |
|---|---|---|
| measurement of parameters reflecting the physical condition | To describe objective and felt fatigue by Fonctional assessment of chronic illness therapy-fatique (41 items scale) | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Valerie SARTORI | Contact | +33 388 25 85 41 | vsartori@strasbourg.unicancer.fr | |
| Joris MALLARD | Contact | + 33 388 25 85 68 | jmallard@strasbourg.unicancer.fr |
| Name | Affiliation | Role |
|---|---|---|
| Roland SCHOTT, Md | Centre Paul Strauss | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Paul Strauss | Recruiting | Strasbourg | 67200 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32903594 | Derived | Mallard J, Hucteau E, Schott R, Petit T, Demarchi M, Belletier C, Ben Abdelghani M, Carinato H, Chiappa P, Fischbach C, Kalish-Weindling M, Bousiniere A, Dufour S, Favret F, Pivot X, Hureau TJ, Pagano AF. Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol. Front Oncol. 2020 Aug 7;10:1304. doi: 10.3389/fonc.2020.01304. eCollection 2020. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003110 | Colonic Neoplasms |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To describe muscular strenght by FPmax: Maximal strenght of finger flexors; (measured in Newton with a dynamometer) |
| change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe muscular strenght by IFP: Fatigability indexof finger flexors; (measured in Newton with a dynamometer) | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe muscular strenght by FIEmax: Maximal isometric strenght of knee extensors; (measured in Newton with a dynamometer) | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe muscular strenght by IFE: Fatigability index of knee extensors; (measured in Newton with a dynamometer) | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of the lean body mass condition | To describe lean body mass by impedancemeter | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of the pulmonary function | Spirometry measures lung function, specifically the amount (volume) of air that can be inhaled and exhaled | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe anxiety by Hospital Anxiety and Depression scale (14 items) | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe physical activity level by by Global Physical Activity questionnaire | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe physical performance index by Short Physical Performance Battery which is a group of measures that combines the results of the gait speed | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe physical performance index by Short Physical Performance Battery which is a group of measures that combines the results of the chair stand | change from baseline physical condition at 12 weeks after the end of the treatment |
| measurement of parameters reflecting the physical condition | To describe physical performance index by Short Physical Performance Battery which is a group of measures that combines the results of the balance tests | change from baseline physical condition at 12 weeks after the end of the treatment |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |